High throughput in vivo phenotypic screening for drug repurposing: Discovery of MLR-1023 a novel insulin sensitizer and novel Lyn kinase activator with clinical proof of concept
Lipinski, Christopher A., Reaume, Andrew G.Langue:
english
Journal:
Bioorganic & Medicinal Chemistry
DOI:
10.1016/j.bmc.2020.115425
Date:
March, 2020
Fichier:
PDF, 1009 KB
english, 2020
File converter
Plus de résultats de recherche
More benefits 
